Author:
Ditonno Francesco,Franco Antonio,Veccia Alessandro,Bertolo Riccardo,Wu Zhenjie,Wang Linhui,Abdollah Firas,Finati Marco,Simone Giuseppe,Tuderti Gabriele,Helstrom Emma,Correa Andres,De Cobelli Ottavio,Ferro Matteo,Porpiglia Francesco,Amparore Daniele,Tufano Antonio,Perdonà Sisto,Bhanvadia Raj,Margulis Vitaly,Brönimann Stephan,Singla Nirmish,Puri Dhruv,Derweesh Ithaar H.,Mendiola Dinno F.,Gonzalgo Mark L.,Ben-David Reuben,Mehrazin Reza,Moon Sol C.,Rais-Bahrami Soroush,Yong Courtney,Sundaram Chandru P.,Moghaddam Farshad Sheybaee,Ghoreifi Alireza,Djaladat Hooman,Autorino Riccardo,Antonelli Alessandro
Reference37 articles.
1. Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, et al. NCCN Guidelines® Insights: Bladder Cancer, Version 3.202 [Internet]. 2023 [cited 2023 Nov 20]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf
2. Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA/SUO guideline;Coleman;J Urol,2023
3. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 update;Rouprêt;Eur Urol,2023
4. The impact of diagnostic ureteroscopy prior to radical nephroureterectomy on oncological outcomes in patients with upper tract urothelial carcinoma: a comprehensive systematic review and meta-analysis;Nowak;J Clin Med,2021
5. The impact of upper tract urothelial carcinoma diagnostic modality on intravesical recurrence after radical nephroureterectomy: a single institution series and updated meta-analysis;Sharma;J Urol,2021